Kingsbury Capital Investment Advisors LLC Ac Immune Sa Transaction History
Kingsbury Capital Investment Advisors LLC
- $65.6 Million
- Q3 2022
A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 27,291 shares of ACIU stock, worth $73,139. This represents 0.13% of its overall portfolio holdings.
Number of Shares
27,291
Previous 18,868
44.64%
Holding current value
$73,139
Previous $68,000
26.47%
% of portfolio
0.13%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding ACIU
# of Institutions
47Shares Held
27.9MCall Options Held
150KPut Options Held
12.4K-
Bvf Inc San Francisco, CA19.5MShares$52.3 Million2.35% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$6.99 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.69MShares$4.54 Million0.42% of portfolio
-
Wells Fargo & Company San Francisco, CA1.11MShares$2.97 Million0.0% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C3952KShares$2.55 Million0.17% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $224M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...